Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

Why Is Humana (HUM) Stock Soaring Today

October 03, 2025 at 15:16 PM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

HUM Cover Image

What Happened?

Shares of health insurance company Humana (NYSE: HUM) jumped 11.9% in the afternoon session after the stock continued to rally as the company provided a positive update on its Medicare Advantage "star" ratings for its 2026 plans.

The company disclosed that while about 20% of its Medicare Advantage members were in plans rated 4 stars or higher, the percentage of members enrolled in the top-tier 4.5-star plans jumped to 14% for 2026. This marked a significant increase from just 3% in 2025. Higher star ratings are important as they can lead to bonus payments from the government and are a key factor for seniors choosing a plan. Adding to the good news, Humana also reaffirmed its full-year earnings guidance for 2025, which indicated confidence in its financial outlook. The update was met with some mixed views from analysts, but the positive ratings news appeared to be the main driver for the stock's rise.

Is now the time to buy Humana? Access our full analysis report here.

What Is The Market Telling Us

Humana’s shares are somewhat volatile and have had 14 moves greater than 5% over the last year. But moves this big are rare even for Humana and indicate this news significantly impacted the market’s perception of the business.

The previous big move we wrote about was 1 day ago when the stock gained 6.4% on the news that the company provided a positive update on its Medicare star ratings and affirmed its full-year earnings guidance.

Humana is up 12.1% since the beginning of the year, but at $283.16 per share, it is still trading 9.2% below its 52-week high of $312 from September 2025. Investors who bought $1,000 worth of Humana’s shares 5 years ago would now be looking at an investment worth $674.80.

Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article